More about the speaker:

In today’s.episode, we are.thrilled to welcome.Ioannis Gkouzionis from.Aisthesis Medical, leading the charge in acute care transformation with their pioneering AI technology. Their flagship product, VIOSync,.is an AI-powered clinical.decision-support system designed to predict.and prevent critical health risks.like sepsis and organ failure, ultimately enhancing patient outcomes and streamlining healthcare processes. Seamlessly integrating with various medical devices, VIOSync creates personalized.digital profiles for each patient, revolutionizing.the way healthcare is delivered.

ℹ️ Ioannis is originally from Thessaloniki, Greece, and is an alumnus of the.Technical University of Crete, where he earned both his MEng (2017) and MSc (2019) in Electrical and Computer Engineering, focusing on.Machine Learning in medical imaging. His journey continued.with a PhD in Clinical Medicine Research at the.Hamlyn Centre for Robotic Surgery, Imperial College London, culminating in the development of a pioneering AI-based surgical imaging guidance.system for gastrointestinal cancer surgery. Having completed my PhD (2023), he has transitioned.into entrepreneurship as.the Co-founder and CEO of Aisthesis Medical, a MedTech startup.dedicated to revolutionising acute care through XAI-driven clinical decision-support.for sepsis prediction and multi-organ failure prevention. His commitment to transforming medical devices into.clinical solutions was.recognised.when he was featured in the.Forbes 30 Under 30 Greece list for 2023.